Back to Creative Planning Creative Planning

CLDXCLDX
31 quarters

Position history for Creative PlanningCreative Planning's holdings in Celldex Therapeutics, Inc.

Creative Planning holds 35,670 shares of CLDX (Celldex Therapeutics, Inc.), worth $1.3M as of 2026-Q2. The position was increased (+6.7% shares). CLDX represents 0.0% of Creative Planning's portfolio.

Current Value

$1.3M

Current Shares

35,670

Total Value Change

+$1.3M

Total Shares Change

+9,464

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
35,670
+6.7%
$1.3M0.0%$37.21
27
2026-Q1
Increased
33,436
+6.5%
$1.1M0.0%$28.94
27
2025-Q4
Decreased
31,404
-5.6%
$852,9330.0%$26.43
0
2025-Q3
Increased
33,270
+11.3%
$860,6940.0%$26.19
28
2025-Q2
Increased
29,902
+26.3%
$608,5050.0%$20.29
30
2025-Q1
Increased
23,669
+19.2%
$429,5920.0%$19.93
28
2024-Q4
Increased
19,854
+34.0%
$501,7110.0%$25.12
31
2024-Q3
New
14,819
-
$503,6980.0%$33.20
33
2024-Q2
Exited
0
-100.0%
$00.0%$37.01
0
2024-Q1
Decreased
4,944
-78.7%
$207,4990.0%$41.97
0
2023-Q4
Increased
23,205
+11.4%
$920,3100.0%$39.66
28
2023-Q3
Increased
20,822
+2.7%
$573,0210.0%$27.52
25
2023-Q2
Increased
20,272
+0.1%
$687,8290.0%$34.58
24
2023-Q1
Increased
20,259
+0.6%
$728,9190.0%$35.58
25
2022-Q4
Increased
20,148
+1.7%
$897,9960.0%$44.57
25
2022-Q3
Increased
19,805
+0.3%
$557,0000.0%$28.35
24
2022-Q2
Increased
19,752
+0.2%
$533,0000.0%$27.83
24
2022-Q1
Unchanged
19,708
0.0%
$671,0000.0%$34.59
0
2021-Q4
Decreased
19,708
-18.3%
$762,0000.0%$38.90
0
2021-Q3
Unchanged
24,108
0.0%
$1.3M0.0%$51.97
0
2021-Q2
Decreased
24,108
-0.2%
$806,0000.0%$35.37
0
2021-Q1
Decreased
24,147
-31.3%
$497,0000.0%$19.73
0
2020-Q4
Decreased
35,147
-0.6%
$616,0000.0%$17.88
0
2020-Q3
Unchanged
35,347
0.0%
$524,0000.0%$15.19
0
2020-Q2
Increased
35,347
+191.0%
$460,0000.0%$12.48
39
2020-Q1
Unchanged
12,147
0.0%
$20,0000.0%$1.77
0
2019-Q4
Decreased
12,147
-3.3%
$27,0000.0%$2.20
0
2019-Q3
Increased
12,566
+0.4%
$27,0000.0%$2.17
19
2019-Q2
Increased
12,513
+2.5%
$34,0000.0%$2.68
20
2019-Q1
Decreased
12,213
-53.4%
$60,0000.0%$4.92
0
2018-Q4
New
26,206
-
$5,0000.0%$3.00
23

Other major holders of CLDX: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used